Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1987 Jul;55(7):1725–1727. doi: 10.1128/iai.55.7.1725-1727.1987

Polymorphonuclear neutrophil chemotaxis modulated by Bacteroides fragilis peptidoglycan.

J F Sperry, J M Burns
PMCID: PMC260586  PMID: 3596807

Abstract

Peptidoglycan was isolated from Bacteroides fragilis with boiling sodium dodecyl sulfate, and some was treated with pronase to eliminate contaminating protein. This peptidoglycan was chemotactic for rabbit polymorphonuclear neutrophils and had even greater chemotactic activity along with some chemokinetic activity after it was partially hydrolyzed with lysozyme. Significant chemotaxis-inhibitory activity was observed for an acid-precipitable component of the lysozyme-treated crude peptidoglycan of B. fragilis.

Full text

PDF
1725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamu S. A., Sperry J. F. Polymorphonuclear neutrophil chemotaxis induced and inhibited by Bacteroides spp. Infect Immun. 1981 Sep;33(3):806–810. doi: 10.1128/iai.33.3.806-810.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Braun V., Rotering H., Ohms J. P., Hagenmaier H. Conformational studies on murein-lipoprotein from the outer membrane of Escherichia coli. Eur J Biochem. 1976 Nov 15;70(2):601–610. doi: 10.1111/j.1432-1033.1976.tb11051.x. [DOI] [PubMed] [Google Scholar]
  3. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
  4. Emori K., Nagao S., Shigematsu N., Kotani S., Tsujimoto M., Shiba T., Kusumoto S., Tanaka A. Granuloma formation by muramyl dipeptide associated with branched fatty acids, a structure probably essential for tubercle formation by Mycobacterium tuberculosis. Infect Immun. 1985 Jul;49(1):244–249. doi: 10.1128/iai.49.1.244-249.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kasper D. L., Seiler M. W. Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis. J Infect Dis. 1975 Oct;132(4):440–450. doi: 10.1093/infdis/132.4.440. [DOI] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Nagao S., Tanaka A., Yamamoto Y., Koga T., Onoue K., Shiba T., Kusumoto K., Kotani S. Inhibition of macrophage migration by muramyl peptides. Infect Immun. 1979 May;24(2):308–312. doi: 10.1128/iai.24.2.308-312.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schwarz U., Asmus A., Frank H. Autolytic enzymes and cell division of Escherichia coli. J Mol Biol. 1969 May 14;41(3):419–429. doi: 10.1016/0022-2836(69)90285-x. [DOI] [PubMed] [Google Scholar]
  9. Sperry J. F., Appleman M. D., Wilkins T. D. Requirement of heme for growth of Bacteroides fragilis. Appl Environ Microbiol. 1977 Oct;34(4):386–390. doi: 10.1128/aem.34.4.386-390.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tanaka A., Emori K. Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP). Am J Pathol. 1980 Mar;98(3):733–748. [PMC free article] [PubMed] [Google Scholar]
  11. Tanaka A., Nagao S., Nagao R., Kotani S., Shiba T., Kusumoto S. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide. Infect Immun. 1979 May;24(2):302–307. doi: 10.1128/iai.24.2.302-307.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Waters R. V., Terrell T. G., Jones G. H. Uveitis induction in the rabbit by muramyl dipeptides. Infect Immun. 1986 Mar;51(3):816–825. doi: 10.1128/iai.51.3.816-825.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES